Global Connected Drug Delivery Devices Market to Reach USD 4,062.7 Million by 2026

The global connected drug delivery devices market size is projected to reach USD 4,062.7 million by 2026, exhibiting a CAGR of 35.4% during the forecast period. However, the market size was USD 361.1 million in 2018. This information is published in a recent report by Fortune Business Insights, titled, "Connected Drug Delivery Devices Market Size, Share & Industry Analysis, By Type (Injectable Devices and Inhalation Devices & Others) By Technology (Bluetooth, NFC, and Others) By End User (Homecare Settings and Hospitals) and Regional Forecast, 2019-2026." As per the report, a rising incidence of diabetes, COPD, and asthma are anticipated to boost the connected drug delivery devices market growth in the coming years.

For More Information : https://www.fortunebusinessinsights.com/industry-reports/connected-drug-delivery-devices-market-100380

Rising Emphasis on Preventive Care of Chronic Diseases to Propel Growth

A rising incidence of chronic diseases across the world is creating more opportunities for the connected drug delivery devices market growth. In 2016, the Global Burden of Disease Study mentioned that the prevalence of COPD went up by approximately 14.7 percent between the period of 1990 to 2015. Besides, connected drug delivery devices possess various novel benefits. So, people are rapidly inclining towards them by replacing the manual devices.

Moreover, an increasing focus on preventive care of chronic disorders is likely to contribute to the market growth in the coming years. The Lancet Respiratory Medicine, for instance, had published a study in 2015 that highlighted that in New Zealand, the adoption of smart inhalers grew up to 84.0 percent amongst asthmatic children from 2014 to 2015.

Bluetooth Segment to Dominate: Need to Connect Smartphones with Drug Delivery Devices Will Surge Demand

In terms of technology, the market is grouped into near field communication (NFC), Bluetooth, and others. The Bluetooth segment is expected to lead the market. It is occurring because of the increasing utilization of this technology for connecting drug delivery devices with smartphones. Apart from that, ease-of-use, as well as high compatibility of this technology with other devices, would drive the growth of this segment. NFC devices, on the other hand, provide superior data transmission and extended battery life. These properties would increase the adoption of these devices in the near future.

Increasing Demand for Digital Medical Devices to Favor Growth in Europe

North America had generated USD 253.0 millionconnected drug delivery devices market revenue in 2018. The region is anticipated to lead the market throughout the forthcoming years. Strategic collaborations, existence of major players, increasing healthcare expenditure, and well-established infrastructure are some of the most significant drivers of the market in this region. Europe is experiencing a rising demand for digital medical devices as well as a higher adoption of connected drug delivery devices on account of an urgent requirement to improve the patient experience.

Asia Pacific is showcasing a rise in the number of awareness programs regarding the cost benefits of connected drug delivery devices. It is also exhibiting an increasing adoption of innovative medical technology. These factors are set to create high growth opportunities.

More Trending Topics from Fortune Business Insights :

Dental Implants Market, Share, Growth, Sales and Drivers Analysis Research Report 2026

Dental Implants Market to Value US$ 5725.7 Mn at CAGR of 5.1% by 2026 | Exclusive Report by Fortune Business Insights

Saurabh is a part of the very talented content team at Fortune Business Insights™. He is a highly-driven writer with extensive experience in market research.